Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-053498

President & CEO sold 100,000 shares at an average $17.37 ($1,737,090)

  • President & CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-10-15 Option exercise +33,333 $7.21 $240,331 346,108 D: show line 1 in the form
ROBIN HOWARD W President & CEO 2019-10-15 Sale −8,833 $16.35 $144,420 337,275 D: show line 2 in the form
ROBIN HOWARD W President & CEO 2019-10-15 Sale −24,500 $17.17 $420,665 312,775 D: show line 3 in the form
ROBIN HOWARD W President & CEO 2019-10-16 Option exercise +33,334 $7.21 $240,338 346,109 D: show line 4 in the form
ROBIN HOWARD W President & CEO 2019-10-16 Sale −33,334 $17.48 $582,678 312,775 D: show line 5 in the form
ROBIN HOWARD W President & CEO 2019-10-17 Option exercise +33,333 $7.21 $240,331 346,108 D: show line 6 in the form
ROBIN HOWARD W President & CEO 2019-10-17 Sale −33,333 $17.68 $589,327 312,775 D: show line 7 in the form
Open-market sales · 100,000 sh · avg $17.37 · $1,737,090

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBIN HOWARD W President & CEO 2019-10-15 Option exercise · Stock Option −33,333 66,667 D: show line 8 in the form
ROBIN HOWARD W President & CEO 2019-10-16 Option exercise · Stock Option −33,334 33,333 D: show line 9 in the form
ROBIN HOWARD W President & CEO 2019-10-17 Option exercise · Stock Option −33,333 0 D: show line 10 in the form
Loading xslF345X03/doc4.xml…